Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Probable zoonotic leprosy in the southern United States.

Truman RW, Singh P, Sharma R, Busso P, Rougemont J, Paniz-Mondolfi A, Kapopoulou A, Brisse S, Scollard DM, Gillis TP, Cole ST.

N Engl J Med. 2011 Apr 28;364(17):1626-33. doi: 10.1056/NEJMoa1010536.

2.

IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis.

Ansari NA, Kumar R, Gautam S, Nylén S, Singh OP, Sundar S, Sacks D.

J Immunol. 2011 Apr 1;186(7):3977-85. doi: 10.4049/jimmunol.1003588. Epub 2011 Feb 28.

3.

Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes.

Tabouret G, Astarie-Dequeker C, Demangel C, Malaga W, Constant P, Ray A, Honoré N, Bello NF, Perez E, Daffé M, Guilhot C.

PLoS Pathog. 2010 Oct 21;6(10):e1001159. doi: 10.1371/journal.ppat.1001159.

4.

IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Jankovic D, Kugler DG, Sher A.

Mucosal Immunol. 2010 May;3(3):239-46. doi: 10.1038/mi.2010.8. Epub 2010 Mar 3. Review.

5.

The innate immune response in leprosy.

Modlin RL.

Curr Opin Immunol. 2010 Feb;22(1):48-54. doi: 10.1016/j.coi.2009.12.001. Epub 2010 Jan 7. Review.

6.

From genome-based in silico predictions to ex vivo verification of leprosy diagnosis.

Geluk A, Spencer JS, Bobosha K, Pessolani MC, Pereira GM, Banu S, Honoré N, Reece ST, MacDonald M, Sapkota BR, Ranjit C, Franken KL, Zewdie M, Aseffa A, Hussain R, Stefani MM, Cho SN, Oskam L, Brennan PJ, Dockrell HM; IDEAL Consortium..

Clin Vaccine Immunol. 2009 Mar;16(3):352-9. doi: 10.1128/CVI.00414-08. Epub 2009 Jan 28.

7.

Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.

Geluk A, van der Ploeg J, Teles RO, Franken KL, Prins C, Drijfhout JW, Sarno EN, Sampaio EP, Ottenhoff TH.

Clin Vaccine Immunol. 2008 Mar;15(3):522-33. doi: 10.1128/CVI.00432-07. Epub 2008 Jan 16.

8.

Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy.

Spencer JS, Dockrell HM, Kim HJ, Marques MA, Williams DL, Martins MV, Martins ML, Lima MC, Sarno EN, Pereira GM, Matos H, Fonseca LS, Sampaio EP, Ottenhoff TH, Geluk A, Cho SN, Stoker NG, Cole ST, Brennan PJ, Pessolani MC.

J Immunol. 2005 Dec 15;175(12):7930-8.

9.

Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection.

Geluk A, Klein MR, Franken KL, van Meijgaarden KE, Wieles B, Pereira KC, Bührer-Sékula S, Klatser PR, Brennan PJ, Spencer JS, Williams DL, Pessolani MC, Sampaio EP, Ottenhoff TH.

Infect Immun. 2005 Sep;73(9):5636-44.

10.

Prospective study of serological conversion as a risk factor for development of leprosy among household contacts.

Douglas JT, Cellona RV, Fajardo TT Jr, Abalos RM, Balagon MV, Klatser PR.

Clin Diagn Lab Immunol. 2004 Sep;11(5):897-900.

11.

The future incidence of leprosy: a scenario analysis.

Meima A, Smith WC, van Oortmarssen GJ, Richardus JH, Habbema JD.

Bull World Health Organ. 2004 May;82(5):373-80.

12.

Serology: recent developments, strengths, limitations and prospects: a state of the art overview.

Oskam L, Slim E, Bührer-Sékula S.

Lepr Rev. 2003 Sep;74(3):196-205. Review.

PMID:
14577464
13.

Genetic dissection of immunity to mycobacteria: the human model.

Casanova JL, Abel L.

Annu Rev Immunol. 2002;20:581-620. Epub 2001 Oct 4. Review.

PMID:
11861613
14.

Immune responses to intracellular bacteria.

Raupach B, Kaufmann SH.

Curr Opin Immunol. 2001 Aug;13(4):417-28. Review.

PMID:
11498297
15.

Use of ML dipstick as a tool to classify leprosy patients.

Buhrer-Sekula S, Sarno EN, Oskam L, Koop S, Wichers I, Nery JA, Vieira LM, de Matos HJ, Faber WR, Klatser PR.

Int J Lepr Other Mycobact Dis. 2000 Dec;68(4):456-63.

PMID:
11332289
16.

Diagnostic assays for leprosy based on T-cell epitopes.

Dockrell HM, Brahmbhatt S, Robertson BD, Britton S, Fruth U, Gebre N, Hunegnaw M, Hussain R, Manadhar R, Murrillo L, Pessolani MC, Roche P, Salgado JL, Sampaio E, Shahid F, Thole JE, Young DB.

Lepr Rev. 2000 Dec;71 Suppl:S55-8; discussion S58-9.

PMID:
11201888
17.

A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.

Dockrell HM, Brahmbhatt S, Robertson BD, Britton S, Fruth U, Gebre N, Hunegnaw M, Hussain R, Manandhar R, Murillo L, Pessolani MC, Roche P, Salgado JL, Sampaio E, Shahid F, Thole JE, Young DB.

Infect Immun. 2000 Oct;68(10):5846-55.

18.

[Leprosy epidemiology in a cohort of household contacts in Rio de Janeiro (1987-1991)].

de Matos HJ, Duppre N, Alvim MF, MachadoVieira LM, Sarno EN, Struchiner CJ.

Cad Saude Publica. 1999 Jul-Sep;15(3):533-42. Portuguese.

PMID:
10502149
19.

Patient contact is the major determinant in incident leprosy: implications for future control.

van Beers SM, Hatta M, Klatser PR.

Int J Lepr Other Mycobact Dis. 1999 Jun;67(2):119-28.

PMID:
10472363
20.

Household and dwelling contact as risk factors for leprosy in northern Malawi.

Fine PE, Sterne JA, Pönnighaus JM, Bliss L, Saui J, Chihana A, Munthali M, Warndorff DK.

Am J Epidemiol. 1997 Jul 1;146(1):91-102.

PMID:
9215227

Supplemental Content

Support Center